Sitemap > Breaking Research > GenitoUrinary Tract Disorders
Displaying 401 - 450 of 759 results
- Development and validation of the overactive bladder satisfaction (OAB-S) questionnaire.
- Absorption, Metabolism and Excretion of [14C]Imidafenacin, a New Compound for Treatment of Overactive Bladder, Following Oral Administration to Healthy Male Subjects.
- Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.
- Validation of the Overactive Bladder Symptom Score.
- Long-Term Tolerability of Tolterodine Extended Release in Children 5-11 Years of Age: Results from a 12-Month, Open-Label Study.
- Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg.
- Pharmacological validation of a model of cystitis pain in the mouse.
- Thiosemicarbazones of Formyl Benzoic Acids as Novel Potent Inhibitors of Estrone Sulfatase.
- Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of Eviprostat((R)), a phytotherapeutic agent for benign prostatic hyperplasia.
- Sexual function, satisfaction, and association of erectile dysfunction with cardiovascular disease and risk factors in cardiovascular high-risk patients: substudy of the ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNT Study in ACE-INtolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND).
- Sildenafil Promotes Ischemia-Induced Angiogenesis Through a PKG-Dependent Pathway.
- Synthesis and evaluation of a phosphonate analogue of the soluble guanylate cyclase activator YC-1.
- Tungstate administration improves the sexual and reproductive function in female rats with streptozotocin-induced diabetes.
- An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat.
- The utility of sildenafil citrate for infertile men with sexual dysfunction: a pilot study.
- Prulifloxacin versus Levofloxacin in the Treatment of Chronic Bacterial Prostatitis: a Prospective, Randomized, Double-Blind Trial.
- Effects of BAY 41-2272 on smooth muscle tone, soluble guanylyl cyclase activity and NADPH oxidase activity/expression in corpus cavernosum from wild-type, neuronal and endothelial NOS null mice.
- Differentially expressed gene networks in cultured smooth muscle cells from normal and neuropathic bladder.
- Prediction of alpha(1)-Adrenoceptor Occupancy in the Human Prostate from Plasma Concentrations of Silodosin, Tamsulosin and Terazosin to Treat Urinary Obstruction in Benign Prostatic Hyperplasia.
- alpha(1)-Adrenoceptors are required for normal male sexual function.
- Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility.
- Demonstration of 5-HT(3) receptor function and expression in the mouse bladder.
- Effect of tamsulosin hydrochloride on lower urinary tract symptoms and quality of life in patients with benign prostatic hyperplasia. Evaluation using bother score.
- Safety and Efficacy of Dapoxetine in the Treatment of Premature Ejaculation: A Double-Blind, Placebo-Controlled, Fixed-Dose, Randomized Study.
- GW427353 (solabegron) a novel selective {beta}3 adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
- Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces the size of experimental endometriosis in the rat model.
- A mouse model of hypercholesterolemia-induced erectile dysfunction.
- Bladder afferent sensitivity in wildtype and TRPV1 knockout mice.
- Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.
- Changes of M(3)-muscarinic receptor protein and mRNA expressions in the bladder urothelium and muscle layer of streptozotocin-induced diabetic rats.
- Targeting Mast Cells in Endometriosis with Janus Kinase 3 Inhibitor, JANEX-1.
- Did Patients With Interstitial Cystitis Who Failed to Respond to Initial Treatment With Bacillus Calmette-Guerin or Placebo in a Randomized Clinical Trial Benefit From a Second Course of Open Label Bacillus Calmette-Guerin?
- Once Daily Trospium Chloride is Effective and Well Tolerated for the Treatment of Overactive Bladder: Results From a Multicenter Phase III Trial.
- Activation of Urothelial-TRPV4 by 4{alpha}PDD contributes to altered bladder reflexes in the rat.
- Botulinum toxin injections for adults with overactive bladder syndrome.
- Design, Synthesis, and in Vivo SAR of a Novel Series of Pyrazolines as Potent Selective Androgen Receptor Modulators.
- Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.
- Intravesical resiniferatoxin for the treatment of women with idiopathic detrusor overactivity and urgency incontinence: A single dose, 4 weeks, double-blind, randomized, placebo controlled trial.
- Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells.
- Gene transfer of the K(ATP) channel restores age-related erectile dysfunction in rats.
- Natural course of lower urinary tract symptoms following discontinuation of alpha-1-adrenergic blockers in patients with benign prostatic hyperplasia.
- Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice.
- Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder.
- Mouse model of erectile dysfunction due to diet-induced diabetes mellitus.
- Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats.
- Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure.
- Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder.
- 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
- Effect of recombinant human endostatin on endometriosis in mice.
- Darifenacin treatment of patients >/= 65 years with overactive bladder: results of a randomized, controlled, 12-week trial.